ZLDPF - Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript
2024-05-16 11:37:03 ET
Zealand Pharma A/S (ZLDPF)
Q1 2024 Results Conference Call
May 16, 2024 08:00 AM ET
Company Participants
Anna Krassowska - VP, IR
Adam Steensberg - President, CEO
David Kendall - CMO
Henriette Wennicke - CFO
Conference Call Participants
Rajan Sharma - Goldman Sachs
Lucy Codrington - Jefferies
Thomas Bowers - Danske Bank
Laura Hindley - Berenberg
Suzanne van Voorthuizen - VLK
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Q1 Financial Results Interim Report First Quarter 2024 Conference Call. At this time all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today Anna Krassowska, Vice President, Investor Relations and Corporate Communications. Please go ahead.
Anna Krassowska
Thank you, operator. Welcome, and thank you for joining us today to discuss Zealand's results for the first quarter of 2024. With me today are the following members of Zealand's management team: Adam Steensberg, President and Chief Executive Officer; Henriette Wennicke, Chief Financial Officer; and David Kendall, Chief Medical Officer.
You can also find the related company announcements and interim report on our website at zealandpharma.com. As described on Slide 2, I caution listeners that, we will be making forward-looking statements that are subject to risks and uncertainties.
Moving to Slide 3, I will turn the call over to Adam Steensberg, President and CEO. Adam?...
Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript